Ryan Maddox, PhD, Epidemiologist, CDC Watch Presentation: 2020 CDC Update on Prion Disease Download Presentation |
Simon Mead, Consultant Neurologist & Clinical Lead, UK National Prion Clinic, National Hospital for Neurology & Neurosurgery Watch Presentation: Genetic Prion Disease and How Genetics Might Help Us Understand Sporadic CJD Download Presentation |
Anne Smith, Executive Director, Clinical Development at Ionis Pharmaceuticals Watch Presentation: Antisense Oligonucleotides for Prion Disease |
Brian Appleby, MD, Medical Director, CJD Foundation, and Director, National Prion Disease Pathology Surveillance Center Watch Presentation: National Prion Disease Pathology Surveillance Center Update |
CJD Foundation Research Grant Recipient Reports Panel 1 - Sonia Vallabh, PhD, Broad Institute of MIT and Harvard
Assessing efficacy of zinc-finger repressors of prion protein as a therapeutic for prion disease - Dr. Holger Wille, University of Alberta
Evaluating prion vaccines in transgenic mouse models of familial prion diseases
Watch Presentation |
CJD Foundation Research Grant Recipient Reports Panel 2 - Fei Wang, PhD, The University of Texas Health Science Center at Houston
Generating Recombinant Human Prions in Large Scale for Structural Studies - Rodrigo Morales, PhD, The University of Texas Health Science Center at Houston
Exploring the zoonotic potential of porcine-derived materials from animals exposed to infectious prions - Dr. Gabriel Haller and Brooke Sadler, PhD, Washington University School of Medicine
The Contribution of Rare Variant and Copy-Number Variation to Risk of Sporadic CJD and Pleiotropy with Other Neurodegenerative Diseases - Candace Mathiason, PhD, Prion Research Center, Colorado State University
Use of Blood-borne Prion Amplification Assays for the Detection of Human Prion Diseases and Biomarker Assessment
Watch Presentation |
CJD Foundation Research Grant Recipient Reports Panel 3 - Anna Poleggi, PhD, Istituto Superiore di Sanità, Rome
Investigating the influence of CYP4X1 gene of age at the onset of CJD as a potential preventive therapeutic approach - Qingzhong Kong, PhD, Case Western Reserve University
The RAP approach for effective prevention and treatment of prion diseases - Natalia do Carmo Ferreira de Araujo, PhD, Rocky Mountain Laboratories, NIH/NIAID
Evaluation of new anti-prion drugs: from drug design to therapeutic efficacy against human prions in vitro, ex-vivo and in vivo
Watch Presentation |
